Literature DB >> 7632960

TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.

Y Sato1, Y Suto, J Pietenpol, T R Golub, D G Gilliland, E M Davis, M M Le Beau, J M Roberts, B Vogelstein, J D Rowley.   

Abstract

Unbalanced translocations as well as interstitial deletions of the short arm of chromosome 12 [del(12p)] are found as recurring chromosomal changes in a broad spectrum of hematopoietic malignancies. These changes result in the hemizygous deletion of genetic material from 12p. We mapped a yeast artificial chromosome containing the TEL gene, a cosmid contig containing part of TEL and a P1 contig containing the KIP1 gene to 12p13. These probes were used for fluorescence in situ hybridization to analyze samples from 47 patients with various hematologic malignancies who had unbalanced translocations (25 patients) leading to loss of 12p or deletions (22 patients) involving 12p13. The patients had acute lymphoblastic leukemia (8 cases), myelodysplastic syndrome (MDS; 11 cases), acute myeloid leukemia (AML; 10 cases), myeloproliferative disorders (4 cases), therapy-related MDS or AML (7 cases), non-Hodgkin's lymphoma (2 cases), and other hematopoietic malignancies (5 cases). All three probes were hemizygously detected in 26 cases and were completely retained in only 9 cases. In 12 cases probes for one of the two genes were deleted, allowing us to map the smallest region of overlap of these deletions to a small genomic region that is bordered on the telomeric side by the TEL gene and on the centromeric side by KIP1. The genomic distance between TEL and KIP1 is estimated to be about 1 to 2 Mbp.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  p27KIP1 deletions in childhood acute lymphoblastic leukemia.

Authors:  H Komuro; M B Valentine; J E Rubnitz; M Saito; S C Raimondi; A J Carroll; T Yi; C J Sherr; A T Look
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Array CGH identifies copy number changes in 11% of 520 MDS patients with normal karyotype and uncovers prognostically relevant deletions.

Authors:  S Volkert; T Haferlach; J Holzwarth; M Zenger; W Kern; M Staller; Y Nagata; K Yoshida; S Ogawa; S Schnittger; C Haferlach
Journal:  Leukemia       Date:  2015-09-22       Impact factor: 11.528

3.  ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7.

Authors:  Meaghan Wall; Kathleen C Rayeroux; Ruth N MacKinnon; Adrian Zordan; Lynda J Campbell
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 4.  Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.

Authors:  T G Mainprize; M D Taylor; J T Rutka; P B Dirks
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Heide Siggelkow; Elenore Samson; Karin Bink; Heinz Höfler; Falko Fend; Jochen Graw; Michael J Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

6.  CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia.

Authors:  Claudia Haferlach; Ulrike Bacher; Alexander Kohlmann; Sonja Schindela; Tamara Alpermann; Wolfgang Kern; Susanne Schnittger; Torsten Haferlach
Journal:  Haematologica       Date:  2011-03-21       Impact factor: 9.941

7.  TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1.

Authors:  R Fenrick; L Wang; J Nip; J M Amann; R J Rooney; J Walker-Daniels; H C Crawford; D L Hulboy; M S Kinch; L M Matrisian; S W Hiebert
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow.

Authors:  L C Wang; W Swat; Y Fujiwara; L Davidson; J Visvader; F Kuo; F W Alt; D G Gilliland; T R Golub; S H Orkin
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

9.  Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.

Authors:  S Kudoh; T S Kumaravel; B Kuramavel; M Eguchi; H Asaoku; H Dohy; M Fujiwara; N Sasaki; K Tanaka; N Kamada
Journal:  Jpn J Cancer Res       Date:  1999-11

10.  Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype.

Authors:  Simone Feurstein; Frank G Rücker; Lars Bullinger; Winfried Hofmann; Georgi Manukjan; Gudrun Göhring; Ulrich Lehmann; Michael Heuser; Arnold Ganser; Konstanze Döhner; Brigitte Schlegelberger; Doris Steinemann
Journal:  BMC Genomics       Date:  2014-09-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.